Skip to main content

ORTHOFIX International N V Value Stock - Dividend - Research Selection

ORTHOFIX International N V

ISIN: US68752M1080, WKN: A2NB0X

Market price date: 26.05.2020
Market price: 33,97 USD




ORTHOFIX International N V Fundamental data and company key figures of the share

Annual reports in USD
Key figures 26-02-2020
Cash flow
Net operating cash flow 32.033.000
Capital Expenditures -20.524.000
Free cash flow 11.509.000
Balance sheet
Total Equity 327.631.000
Liabilities & Shareholders equity 495.620.000
Income statement
Net income -28.462.000
Eps (diluted) -1,510
Diluted shares outstanding 18.849.000
Net sales/revenue 459.955.000

Fundamental ratios calculated on: 26-05-2020

Ratios
Key figures 26-05-2020
Cash flow
P/C 19,99
   
P/FC 55,64
Balance sheet
ROI-5,74
ROE66,11
Income statement
P/E-22,50
Div. Yield0,00%
P/B1,95
P/S1,39


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolOFIX
Market Capitalization635.588.288,00 USD
CountryNetherlands Antilles
IndicesNASDAQ Comp.
SectorsHealth service
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.orthofix.com


Description of the company

Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.orthofix.com